The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis
RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the first interim analysis.
 
Peter A. Fasching
Honoraria - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst)
 
Arnd Nusch
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - Amgen; Novartis
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Bernhard Heinrich
Honoraria - Boehringer Ingelheim; Lilly; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Roche
Research Funding - Boehringer Ingelheim; Lilly; Novartis; Roche; Sanofi
 
Sara Brucker
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis
 
Thomas Decker
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis
 
Christian M. Kurbacher
Honoraria - Amgen; Novartis; Onkotrakt; Pfizer; PharmaMar; RIEMSER; Roche; Tesaro
Consulting or Advisory Role - Amgen; Axios; Hilotherm; NewCo Pharma; Novartis; RIEMSER; Roche; Tesaro
Research Funding - AstraZeneca; Axios; Merck Sharp & Dohme; NewCo Pharma; Novartis; Pfizer; PharmaMar; RIEMSER
Travel, Accommodations, Expenses - Amgen; Hexal; PharmaMar; Tesaro; Teva
 
Hans Tesch
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Petra Krabisch
No Relationships to Disclose
 
Christoph Mundhenke
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Research Funding - Novartis
 
Wolfgang Janni
Honoraria - Janssen Diagnostics
Research Funding - Janssen Diagnostics
 
Diana Lueftner
No Relationships to Disclose
 
Andreas Schneeweiss
Honoraria - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Pfizer (Inst); Roche Pharma AG (Inst)
Research Funding - Celgene (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Roche
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Gernot Guderian
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Claudia Voges
Employment - Novartis
 
Joerg Schubert
Employment - Novartis
 
Sherko Kummel
Honoraria - Amgen; Celgene; Daiichi Sankyo; Novartis; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Celgene; Roche